The OHSU Knight Cancer Institute is a pioneer in personalized cancer treatment and research, led by Dr. Brian Druker, whose development of Gleevec transformed Chronic Myeloid Leukemia from a fatal disease to a manageable one and proved that targeted therapies can work. The institute focuses on precision oncology, the early detection, prevention, and treatment of cancer, and creating a welcoming and supportive environment for its caregivers, researchers, and support personnel. Knight affiliates subscribe to three guiding principles: we are bold, we are supportive, and we work as a connected team in our fight to end cancer as we know it. We¿d love for you to join us!
The mission of the Early Detection Clinical Research group is to help detect and stop lethal cancers at the earliest stage because early detection saves lives. We are committed to increasing the diversity of the campus community. We are dedicated to promoting inclusion and multiculturalism to build a successful organization by having outstanding researchers of diverse backgrounds work together.
Every Knight Cancer employee is expected to embody our guiding principles:
This position is not a summer position.
Enrolled in, or on vacation from, or otherwise registered in:
Apply online. Please be sure to upload a Cover Letter and Resume/CV.
#knightcancerjobs #knightresearchandlabjobs #knightstudentjobs #knightnews
Software Powered by ICIMS
www.icims.com